Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure

被引：0
|
作者：
Vasyuk, Yu. A.
Yuschuk, E. N.
Shkolnik, E. L.
Khadzegova, A. B.
Sadulaeva, I. A.
Vitko, N. X.
Vakhromeeva, M. N.
机构：
来源：
TERAPEVTICHESKII ARKHIV | 2007年 / 79卷 / 02期
关键词：
chronic heart failure; myocardial metabolism; hybernation; trimethasidine MB; 3-(2,2,2-trimethylhydrasinium) propionate dihydrate; positron-emission tomography;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / 58
页数：8
相关论文
共 50 条
  • [31] sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure
    Barutaut, Manon
    Fournier, Pauline
    Peacock, William F.
    Evaristi, Maria-Francesca
    Dambrin, Camille
    Caubere, Celine
    Koukoui, Francois
    Galinier, Michel
    Smih, Fatima
    Rouet, Philippe
    ACTA CARDIOLOGICA, 2020, 75 (08) : 739 - 747
  • [32] Diagnostic value of galectin-3 level in patients with chronic heart failure and type 2 diabetes
    Snetkova, A. A.
    Timofeeva, N. Yu.
    Zadionchenko, V. S.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (02) : 139 - 143
  • [33] Independent predictors of heart failure in patients with type 2 diabetes and chronic kidney disease: modeling from the CREDENCE trial
    Mahaffey, K. W.
    Li, J.
    Chang, T., I
    Sarraju, A.
    Agarwal, R.
    Charytan, D. M.
    Greene, T.
    Heerspink, H. J. L.
    Levin, A.
    Neal, B.
    Pollock, C.
    Yavin, Y.
    Jardine, M.
    Perkovic, V
    Cannon, G. P.
    EUROPEAN HEART JOURNAL, 2020, 41 : 1175 - 1175
  • [34] Sodium-glucose co-transporter 2 inhibitors for heart failure: clinical trial efficacy and clinical practice effectiveness
    Khan, Muhammad Shahzeb
    Fonarow, Gregg C.
    Greene, Stephen J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (06) : 1023 - 1025
  • [35] Renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure: the RECEDECHF trial
    Mordi, Natalie A.
    Mordi, Ify R.
    Singh, Jagdeep S.
    McCrimmon, Rory J.
    Struthers, Allan D.
    Lang, Chim C.
    SCOTTISH MEDICAL JOURNAL, 2021, 66 (02) : NP7 - NP8
  • [36] CUPID 2: A Phase 2b Trial Investigating the Efficacy and Safety of the Intracoronary Administration of AAV1/SERCA2a in Patients with Advanced Heart Failure
    Greenberg, Barry
    Butler, Javed
    Felker, G. Michael
    Ponikowski, Piotr
    Voors, Adriaan A.
    Jaski, Brian
    Lyon, Alexander R.
    Pogoda, Janice M.
    Rudy, Jeffrey J.
    Zsebo, Krisztina M.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (11) : 939 - 940
  • [37] Efficacy of Short-Term Therapy With Meldonium in Patients With Chronic Heart Failure of Ischemic Etiology and Type 2 Diabetes Mellitus
    Statsenko, M. E.
    Turkina, S. V.
    Fabritskaya, S. V.
    Shilina, N. N.
    KARDIOLOGIYA, 2017, 57 (04) : 58 - 63
  • [38] A Systematic Review and Meta-Analysis of the Safety and Efficacy of SGLT2 Inhibitors in Chronic Heart Failure in ACHD Patients
    Das, Bibhuti B.
    Niu, Jianli
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2025, 25 (02) : 231 - 240
  • [39] Comparative efficacy of a high or low dose of interferon alpha(2b) in chronic hepatitis C: A randomized controlled trial
    Tassopoulos, NC
    Karvountzis, G
    Touloumi, G
    Delladetsima, JK
    Papatheodoridis, GV
    Katsoulidou, A
    Retalis, G
    Hatzakis, A
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (09): : 1734 - 1738
  • [40] Decreased levels of matrix metalloproteinases-2 and-3 in patients with diabetes mellitus and chronic heart failure
    Chalikias, GK
    Tziakas, DN
    Stakos, DA
    Hatzinikolaou, HI
    Apostolou, EK
    Trypsianis, GA
    Papadopoulou, EG
    Tentes, IK
    Kortsaris, AX
    Chatseras, DI
    DIABETOLOGIA, 2003, 46 : A374 - A374
12345